| Secondary outcomes | ||||
| (dichotomous outcome) | Participants analysed | Number of events in the groups: E = experimental C = control |
Bias of the outcome | |
| Lung injury | Maximum follow‐up | E (n) | E (n) | L / U / H |
| C (n) | C (n) | |||
| End of trial intervention period | E (n) | E (n) | L / U / H | |
| C (n) | C (n) | |||
| Acute myocardial infarction | Maximum follow‐up | E (n) | E (n) | L / U / H |
| C (n) | C (n) | |||
| End of trial intervention period | E (n) | E (n) | L / U / H | |
| C (n) | C (n) | |||
| Stroke | Maximum follow‐up | E (n) | E (n) | L / U / H |
| C (n) | C (n) | |||
| End of trial intervention period | E (n) | E (n) | L / U / H | |
| C (n) | C (n) | |||
| Severe sepsis | Maximum follow‐up | E (n) | E (n) | L / U / H |
| C (n) | C (n) | |||
| End of trial intervention period | E (n) | E (n) | L / U / H | |
| C (n) | C (n) | |||